$PCTL Hitting up here @ 0.0250 (+5.93%) + News! C
Post# of 107257
(Total Views: 185)
Posted On: 01/29/2021 1:44:44 PM
$PCTL Hitting up here @ 0.0250 (+5.93%) + News! CORRECTING And REPLACING PCT LTD Announces Significant Progress In Commercializing The Annihilyzer(R) Infection Control System In The United Kingdom
First paragraph, ticker exchange should read: (OTC Pink: "PCTL"
(instead of (OTCQB: "PCTL" ).
The updated release reads:
PCT LTD ANNOUNCES SIGNIFICANT PROGRESS IN COMMERCIALIZING THE ANNIHILYZER(R) INFECTION CONTROL SYSTEM IN THE UNITED KINGDOM
PCT LTD (OTC Pink: "PCTL" is pleased to announce that in conjunction with PCT (Europe) Ltd., their efforts to commercialize its Annihilyzer(R) Infection Control Systems with the United Kingdom's National Health Service (NHS) has taken a significant step forward, according to a senior executive of NTH Solutions UK, a subsidiary of North Tees NHS Foundation Trust, who are also PCT Europe's exclusive trading partner.
In a recent communication to Mr. Barry Dunn, Managing Director of PCT (Europe) Ltd, PCTL was informed that North Tees Hospital has successfully completed its first phases of testing the Annihilyzer(R) and will now begin a robust 12 week evaluation study on several live and occupied Wards, including one dedicated to COVID-19 patients. The Hospital will commence the final evaluation of PCTL's Annihilyzer(R) on the live Wards following initial results that provided the evidence needed to allow the Hospital's Infection Control Director to authorize the final phase of testing. This live study will be fully supported by the Infection Control and Operational Decontamination Cleaning Teams.
https://www.barchart.com/story/stocks/quotes/...ed-kingdom
First paragraph, ticker exchange should read: (OTC Pink: "PCTL"
(instead of (OTCQB: "PCTL" ). The updated release reads:
PCT LTD ANNOUNCES SIGNIFICANT PROGRESS IN COMMERCIALIZING THE ANNIHILYZER(R) INFECTION CONTROL SYSTEM IN THE UNITED KINGDOM
PCT LTD (OTC Pink: "PCTL"
is pleased to announce that in conjunction with PCT (Europe) Ltd., their efforts to commercialize its Annihilyzer(R) Infection Control Systems with the United Kingdom's National Health Service (NHS) has taken a significant step forward, according to a senior executive of NTH Solutions UK, a subsidiary of North Tees NHS Foundation Trust, who are also PCT Europe's exclusive trading partner. In a recent communication to Mr. Barry Dunn, Managing Director of PCT (Europe) Ltd, PCTL was informed that North Tees Hospital has successfully completed its first phases of testing the Annihilyzer(R) and will now begin a robust 12 week evaluation study on several live and occupied Wards, including one dedicated to COVID-19 patients. The Hospital will commence the final evaluation of PCTL's Annihilyzer(R) on the live Wards following initial results that provided the evidence needed to allow the Hospital's Infection Control Director to authorize the final phase of testing. This live study will be fully supported by the Infection Control and Operational Decontamination Cleaning Teams.
https://www.barchart.com/story/stocks/quotes/...ed-kingdom
(0)
(0)